Development of the Functional Assessment of Cancer Therapy–Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs

Aaron R. Hansen*, Kari Ala-Leppilampi, Chris McKillop, Lillian L. Siu, Philippe L. Bedard, Albiruni R. Abdul Razak, Anna Spreafico, Srikala S. Sridhar, Natasha Leighl, Marcus O. Butler, David Hogg, Adrian Sacher, Amit M. Oza, Rany Al-Agha, Catherine Maurice, Christopher T. Chan, Shane Shapera, Jordan J. Feld, Rosane Nisenbaum, Kimberly WebsterDavid Cella, Janet Parsons

*Corresponding author for this work

Research output: Contribution to journalArticle

3 Scopus citations

Fingerprint Dive into the research topics of 'Development of the Functional Assessment of Cancer Therapy–Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs'. Together they form a unique fingerprint.

Medicine & Life Sciences